Monday, July 28, 2014 9:21:02 PM
The affordability, portability and diversity of PEMF Actipatch devices will catch the eyes and open wallets of the general public.....two words "Huge Opportunity" is flashing in the executive offices of the large pharm that is in negotiations with a licensee agreement with Biel!
http://www.pemftindia.com/views-of-experts-about-pemfs.html
"Dr Gabi Nindl, a respected investigator and teacher at the University of Indiana School of Medicine recently stated, “optimistically, PEMF could replace many pharmaceutical and surgical interventions currently used to provide safe, effective treatment for inflammation.”
Never buy/sell a stock on my recommendation alone. Always do your own DD and be aware of the risks!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM